TAIPEI (Reuters) - The first agreement signed under a trade initiative between Taiwan and the United States will come into force on Tuesday, both governments announced, as Taipei hopes a raft of ongoing talks will eventually lead to a free trade deal.
Qualcomm vs. Taiwan Semiconductor: Which Is the Better Chip Stock to Buy?
Semiconductor technology is at the core of artificial intelligence (AI). As AI continues to evolve, the semiconductor industry will continue to play an important role in molding its future. Qualcomm ...
Taiwan Semiconductor Extends Lead As Top Chipmaker
Taiwan Semiconductor Manufacturing Co (NYSE:TSM) maintained its global wafer foundry business turf in the third quarter of 2024.
China begins military movements around Taiwan as the island braces for potential drills
Multiple formations of Chinese naval and coast guard vessels are moving in waters around the Taiwan Strait and the Western Pacific, Taiwan’s Defense Ministry said Monday, as the island braces for ...
Taiwan raises alert as China deploys 90 ships in likely exercises
Taiwan raised its alert level on Monday saying China has set up seven zones of reserved airspace and deployed naval fleets and coast guard boats in what a security source described as the first ...
Taiwan November exports expand faster
Taiwan's exports rose more than expected in November benefiting from the booming artificial intelligence (AI) industry and a bounce back in demand from top trading partner China, with the outlook ...
Intel needs a core business strategy: Morris Chang
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) founder Morris Chang (張忠謀) yesterday said that Intel Corp would find itself in the same predicament as it did four years ago if its board does not ...
Chinese Taipei Boosts APEC’s Sustainable Growth Path
Chinese Taipei has voluntarily contributed USD 1,000,000 in additional funding for APEC member initiatives to enhance human security, digital ...
Sui’s Path Forward: Bybit Web3 and Sui Foundation to Host Exclusive Debate Live at Taipei Blockchain Week
A special livestream event, Mass Adoption vs. Native Growth: What’s Next for Sui, will take place at 8 AM UTC on Dec. 13, 2024, live at the Taipei Blockchain Week where the audience can watch the ...
Taiwan’s Patent System: Key Differences and Challenges for Foreign Companies
Explore Taiwan's unique patent system and how it compares with the U.S. and Europe, including key differences in patent types, examination processes, and challenges for foreign companies.
Sercomm and Harmonic Announce Strategic Collaboration on DOCSIS 4.0 Unified Technology
Sercomm (TWSE: 5388) and Harmonic (NASDAQ: HLIT) today announced an exclusive technology collaboration to advance DOCSIS 4.0 unified technologies. As part of this partnership, Sercomm will introduce ...
Taiwan Accelerates Production of Wanjian-1 Aerial Bombs and Completes Development of Wanjian-2 Version
As part of Taiwan's Ministry of Defense program to strengthen the country's naval and air capabilities, mass production of 150 Wanjian-1 aerial bombs will be completed by the end of December 2024. O ...
Taiwan set for 2nd biggest export year ever
TAIPEI (Taiwan News) — Taiwan is on track to record its second-highest year ever for exports, driven by AI and the semiconductor industry, the Ministry of Finance announced on Monday (Dec. 9). Exports ...
Development in Taipei Threatens ‘The Lungs of the City’ – TaiwanPlus News
The Guandu Plains, one of Taipei's largest agricultural areas and known as the "lungs" of the city, are under threat from encroaching urban development. Local farmers and residents are pushing back.
China Sends Ships to Taiwan in Response to Leader’s US Visit
China's naval maneuvers near Taiwan intensified over the weekend, with Taiwan's Defense Ministry reporting 14 warships, seven military aircraft, and four balloons in the region. The heightened activity follows Taiwanese President Lai Ching-te's visits to Pacific allies,
Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR® AI platform, today announced that the first patient has been enrolled and dosed in Taiwan for its Phase 2 HARMONIC™ clinical trial evaluating LP-300 in never-smoker patients with non-small cell lung cancer (NSCLC) who have progressed after ...